These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6316195

  • 1. Characterization of a kappa-agonist-like antinociceptive action of tifluadom.
    Upton N, Gonzalez JP, Sewell RD.
    Neuropharmacology; 1983 Oct; 22(10):1241-2. PubMed ID: 6316195
    [Abstract] [Full Text] [Related]

  • 2. The interaction of the two isomers of the opioid benzodiazepine tifluadom with mu-, delta-, and kappa-binding sites and their analgesic and intestinal effects in rats.
    Petrillo P, Amato M, Tavani A.
    Neuropeptides; 1985 Feb; 5(4-6):403-6. PubMed ID: 2860598
    [Abstract] [Full Text] [Related]

  • 3. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG, West DC, Headley PM.
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [Abstract] [Full Text] [Related]

  • 4. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
    Dong XW, Parsons CG, Headley PM.
    Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
    [Abstract] [Full Text] [Related]

  • 5. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF, Cook L.
    J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli.
    Millan MJ.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):334-41. PubMed ID: 2571722
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Kappa-opioid diuretic effects of tifluadom, a benzodiazepine opioid agonist.
    Leander JD.
    J Pharm Pharmacol; 1984 Aug; 36(8):555-6. PubMed ID: 6148404
    [Abstract] [Full Text] [Related]

  • 10. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM, Dykstra LA.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S, Bhargava HN.
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [Abstract] [Full Text] [Related]

  • 16. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ, Takemori AE.
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The influence of tifluadom on cholecystokinin-induced antinociception.
    Gericke M, Morgenstern R, Ott T.
    Eur J Pharmacol; 1990 May 03; 180(1):187-90. PubMed ID: 2365002
    [Abstract] [Full Text] [Related]

  • 20. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
    Craft RM, Dykstra LA.
    J Pharmacol Exp Ther; 1992 Jan 03; 260(1):334-42. PubMed ID: 1309877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.